Impact of COVID-19 Pandemic on Temporal Trends of Hemostasis Test in France: A Retrospective Analysis of 9 Years of National Health Data [0.03%]
新冠肺炎疫情对法国凝血检测 temporal trends 的影响：一项基于 9 年全国卫生数据的回顾性分析研究
Nûn K Bentounes,Richard Chocron,Aurélien Philippe et al.
Nûn K Bentounes et al.
Occurrence of Hospital-Associated Thrombosis in the Setting of Current Thromboprophylaxis Strategies: An Observational Cross-Sectional Study [0.03%]
住院相关血栓在当前抗凝策略下的发生率：横断面研究
Chantal Visser,Marieke J H A Kruip,Janet Brantsma-Van der Graaf et al.
Chantal Visser et al.
Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation [0.03%]
房颤患者直接口服抗凝药治疗不依从的流行病学特征及影响因素分析
Sabine F B van der Horst,Tim A C de Vries,Gordon Chu et al.
Sabine F B van der Horst et al.
Background For most patients with newly diagnosed atrial fibrillation (AF), direct oral anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern that the lack of monitoring may impair therapy adherence and ...
Gabriel Alejandro Zúñiga,Pranav Kandula,Hardy Sandefur et al.
Gabriel Alejandro Zúñiga et al.
Despite anticoagulation recommendations, patients may present with recurrent events. While medication adherence is always a concern, assessment of anticoagulation failure demands a systematic approach, taking into account the potential limi...
Periinterventional Management of Edoxaban in Major Procedures: Results from the DRESDEN NOAC REGISTRY [0.03%]
德雷斯顿NOAC登记处关于依度沙班在重大手术或操作中管理的研究结果
Christina Köhler,Luise Tittl,Ulrike Hänsel et al.
Christina Köhler et al.
Background Edoxaban is a non-vitamin K dependent oral anticoagulant (NOAC) licensed for venous thromboembolism (VTE) treatment or stroke prevention in atrial fibrillation. Major surgical procedures are not uncommon in anticoagulated patient...
Surgery As a Trigger for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study [0.03%]
基于人群的病例交叉研究中手术作为静脉血栓栓塞症的诱发因素的研究结果
Dana Meknas,Sigrid K Brækkan,John-Bjarne Hansen et al.
Dana Meknas et al.
Background Surgery is a major transient risk factor for venous thromboembolism (VTE). However, the impact of major surgery as a VTE trigger has been scarcely investigated using a case-crossover design. Aim To investigate the role of major s...
Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan [0.03%]
日本艾美赛珠单抗临床研究标本库中抗艾美赛珠单抗抗体的特征分析
Naoki Matsumoto,Hiroto Abe,Ryohei Kawasaki et al.
Naoki Matsumoto et al.
Judith J de Vries,Chantal Visser,Maureen van Ommen et al.
Judith J de Vries et al.
Background Fibrinogen variants as a result of alternative messenger RNA splicing or protein degradation can affect fibrin(ogen) functions. The levels of these variants might be altered during coronavirus disease 2019 (COVID-19), potentially...
Kashyap Patel,Omaike Sikder,Nikhil Nair et al.
Kashyap Patel et al.
Effect of PCC on Thrombin Generation among Patients on Factor Xa Inhibitors with Major Bleeding or Needing Urgent Surgery (GAUGE): Design and Rationale [0.03%]
PCC对FXa抑制剂相关大出血或需紧急手术患者血栓形成影响的前瞻性研究(GAUGE)：设计与理由
Joseph R Shaw,Ubabuko Unachukwu,Joseph Cyr et al.
Joseph R Shaw et al.
Background Direct factor Xa inhibitors (FXaIs) account for most oral anticoagulant use and FXaI-associated bleeding events are common. Clinicians have variable national and regional access to specific FXaI reversal agents such as andexanet ...